The elderly, defined here as subjects aged ≥ 65 years, are among at-risk subjects for whom annual influenza vaccination is recommended. For the 2018/19 season, three vaccine types are available for the elderly in Italy: trivalent inactivated vaccine (TIV), adjuvanted TIV (aTIV) and quadrivalent inactivated vaccines (QIV). No health technology assessment (HTA) of seasonal influenza vaccination in the elderly has previously been conducted in Italy.
Adjuvanted influenza vaccine for the Italian elderly in the 2018/19 season: an updated health technology assessment / de Waure, Chiara; Boccalini, Sara; Bonanni, Paolo; Amicizia, Daniela; Poscia, Andrea; Bechini, Angela; Barbieri, Marco; Capri, Stefano; Specchia, Maria Lucia; Di Pietro, Maria Luisa; Arata, Lucia; Cacciatore, Pasquale; Panatto, Doanatella; Gasparini, Roberto. - In: EUROPEAN JOURNAL OF PUBLIC HEALTH. - ISSN 1101-1262. - ELETTRONICO. - (2019), pp. 1-6. [10.1093/eurpub/ckz041]
Adjuvanted influenza vaccine for the Italian elderly in the 2018/19 season: an updated health technology assessment
Boccalini, Sara;Bonanni, Paolo;Bechini, Angela;BARBIERI, MARCO;
2019
Abstract
The elderly, defined here as subjects aged ≥ 65 years, are among at-risk subjects for whom annual influenza vaccination is recommended. For the 2018/19 season, three vaccine types are available for the elderly in Italy: trivalent inactivated vaccine (TIV), adjuvanted TIV (aTIV) and quadrivalent inactivated vaccines (QIV). No health technology assessment (HTA) of seasonal influenza vaccination in the elderly has previously been conducted in Italy.
| File | Dimensione | Formato | |
|---|---|---|---|
|
Adjuvanted influenza vaccine for the Italian elderly in the 2018.2019.pdf
accesso aperto
Tipologia:
Pdf editoriale (Version of record)
Licenza:
Open Access
Dimensione
368.58 kB
Formato
Adobe PDF
|
368.58 kB | Adobe PDF |
I documenti in FLORE sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
